Businesses, Industries, CEOs, liquidity providers, venture capitalists, economists, regulators, and people interested in blockchain trade are invited to attend the 8^th edition of Blockchain Africa Conference 2022, being held on March 17-18, 2022, as a virtual event organized by Bitcoin Events. Bitcoin Events is the pioneer events company to host world-class bitcoin and blockchain conferences in Africa. The Bitcoin Event conferences offer a global stage for industry leaders and influential personas of the cryptocurrency and blockchain industries. The dignitaries connect and discuss the future trends as well as the social, economic, and financial aspects of the global cryptocurrency economy. These speakers are eminent personalities who share insights and discuss how blockchain technology can be included in the mainstream finance for payments, remittance, and other business transactions in fields like renewable energy, remittances, farming and agriculture, community currencies and more. Conducting cryptocurrency in a safe and regulated environment where the digital assets of the users are secure, is one of the core issues at the Blockchain Africa Conference 2022. The panel will take up discussions on how businesses and people of South Africa can leverage Self-Sovereign Identity (“SSI”) and what are the hurdles involved in its successful adoption. As the current traditional identity systems are fragmented, insecure and exclusive, blockchain technology can be a boon owing to the secure management and tamper-proof infrastructure that ensures the safety of digital assets of enterprises, users and management systems. In a keynote address, Dr. Edward Obasi, COO, DafriGroup, PLC, will discuss how DafriBank Digital Limited (a Comoros licensed Digital Bank set up by DafriGroup) conducts banking, finance and crypto transactions in Africa and worldwide. Other discussions and sessions include in-depth insights into the Next Generation of Cross-Border Payments in Africa and how blockchain smart contracts are being leveraged and how they redefine the future of businesses. Blockchain is slowly gaining ground and has now become the preferred mode of financial transaction by many leading organizations. The Blockchain Conference Africa 2022 is a big step for transparency and understanding of this medium of transaction for seamless business management and the underlying challenges with infrastructure and regulatory frameworks to achieve these goals. This is in keeping with the goal of the conference that started with ‘Beyond the Hype’, ‘From Hype to Mainstream’ and now ‘Ready for Business?’ To learn more, please visit https://blockchainafrica.co/.

• App simplifies process of reading, studying and analyzing, allowing readers to stay on top of information they need to know
• “Forbes” claims multitasking masters are simply switching back and forth between two or more objects
• Relying on artificial intelligence rather than human intelligence, Pluaris can do a myriad of things simultaneously

Multitasking is a myth, declared a recent “Forbes” article, dashing the belief of overachievers everywhere who thought they had mastered the art of doing more than one thing at a time. However, while “Forbes” claims people are unable to multitask, Nowigence Inc. (NOWG) has developed an off-the shelf, cloud-based, artificial intelligence (“AI”) platform, called Pluaris(TM), that actually can successfully handle more than one task at a time. “Most of us, especially us Type A’s, like to think we’re great multitaskers,” states the article. “We check our email and text messages while listening in on a Zoom meeting, working on a spreadsheet, and scrolling Twitter or a news site. In this age of distraction, multitasking seems like a useful superpower to have. Unfortunately, it isn’t even real. That’s right — multitasking is a myth.” Instead, claims “Forbes,” what multitasking masters are actually doing is switching back and forth between two or more objects, which the publication calls “task switching.” “Often, there’s little rhyme or reason for the switching,” the article notes. “That’s especially the case when we let little distractions and ongoing worries interrupt our focus. When we’re task switching, we aren’t fully engaged in anything. Task switching can take a significant toll. You may be surprised to learn that toggling back and forth between tasks—even just taking 30 seconds to send a text—slows down and can even derail your mental ability for up to a full half hour afterward.” The article goes on to point out that task switchers often become more forgetful, dumber and more stressed out. While multitasking might not be a real thing, Nowigence’s Pluaris is. Relying on artificial intelligence rather than human intelligence, Pluaris can do a myriad of things simultaneously. The game-changing app automatically monitors public news sources for identified topics of interest while also gathering information together and providing summaries, extracting intelligence, and creating graphical analysis. It’s the ultimate multitasking platform. And while Pluaris automates reading and analysis of textual data, the app’s users can focus on one thing: learning more in less time. The app simplifies the process of reading, studying, and analyzing, allowing readers to stay on top of the information they need to know. Simplifying learning is what Nowigence is all about. The company is committed to helping individuals, teams and enterprises quickly distill knowledge from massive amounts of textual data, both public and private. By integrating state-of-the-art data processing techniques in an intuitive interface at an affordable subscription price, Pluaris puts the power of data science into the hands of consumers. For more information, visit the company’s website at www.Nowigence.com. NOTE TO INVESTORS: The latest news and updates relating to Nowigence are available in the company’s newsroom at https://ibn.fm/NOW

• Over 140 rare cannabinoids exist in the cannabis plant – some with the potential to have more therapeutic benefits than those cannabinoids found prominently in the plant
• InMed and subsidiary BayMedica plan to release several rare cannabinoid products in the first half of 2022
• Combination of complementary InMed and BayMedica business models key to increasing shareholders’ value

In 2020, the global health and wellness market reached $4.436 trillion and is expected to grow at a CAGR of 5.5% from 2021 to 2030, resulting in an estimated value of $7.7 trillion by the end of the forecasted period (https://ibn.fm/BjCNi). The primary driver for the market is the rise in chronic diseases globally. The lifestyles led by individuals have resulted in a high prevalence of stress, depression, anxiety, cancer, diabetes, and other health-related issues. On top of these conditions, the lack of a proper diet has reduced the intake of essential minerals and nutrients required for healthy function by every body. The rapid growth of the biopharmaceutical industry and the constant research and development of health and wellness products boost the medicinal industry with life-saving drugs and treatments for some of the most devastating illnesses and diseases. Six areas make up a consumer’s view of wellness – better health, better fitness, better nutrition, better appearance, better sleep, and better mindfulness. According to a McKinsey & Company survey, worldwide, the most money spent was on products that promote better health (https://ibn.fm/Jhzpl). The majority of the spending (70%) was product-related, but over the next year, the services industry is expected to grow as well. InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates and the manufacturer of technologies for pharmaceutical-grade rare cannabinoids, has dedicated itself to developing new therapeutic alternatives for the treatment of conditions with high unmet medical needs. Together with its subsidiary, BayMedica, InMed increases shareholder value by combining two complementary business models. There are over 140 rare cannabinoids that naturally occur at low amounts in the cannabis plant. InMed initially focused on the therapeutic benefits of cannabinol (“CBN”), which shows increased potential over other cannabinoids more prominently found in the cannabis plant. CBN is also the active pharmaceutical ingredient in two lead programs conducted by InMed for dermatological (INM-755) and ocular (INM-088) diseases. The manufacturing process used by InMed and recently acquired subsidiary BayMedica is unparalleled in the industry. There is no “one-size-fits-all” approach to cannabinoid manufacturing, so multiple avenues are required to realize the maximum outcome for the targeted cannabinoid. InMed and BayMedica, like a well-oiled machine, work together using biosynthesis, chemical synthesis, and the proprietary IntegraSyn(TM) manufacturing models. Biosynthesis is preferred for complex structures at a large scale and is well suited for the consumer and health industry. Chemical synthesis is preferred for cannabinoids with simple structures and offers the potential for less equipment and lower capital requirements. There is also a potential for easier validation with chemical synthesis, and it is also an important component of secondary IntegraSyn(TM) differentiation steps. IntegraSyn(TM) utilizes high-efficiency biosynthesis-derived enzymes, allowing the flexibility to shift from the production of one cannabinoid to a range of cannabinoids. This proprietary method makes it easy to scale up to mass production, it is commonly available, and it is cost-efficient when dealing with startup materials. Together, InMed and BayMedica plan to launch a series of rare cannabinoids into the health and wellness sector during Q1 2022, starting with cannabicitran (“CBT”). “We are delivering on our objective to launch additional rare cannabinoids in early 2022 in response to inbound demand,” BayMedica SVP and General Manager Shane Johnson said (https://ibn.fm/lsr3m). “By midyear, we expect to have at least four rare cannabinoids available for the health and wellness markets, positioning us as a leading large-scale supplier of high-quality rare cannabinoids in these sectors.” For more information, visit the company’s website at www.InMedPharma.com. NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM

• INND continues to broaden its reach to help more of the 70 million individuals in North America who suffer from hearing loss
• Company deploys multichannel market strategy involving e-commerce and in-store presence to help consumers access hearing aids
• With a full range of good quality yet affordable hearing aid solutions targeted at its large and growing market, INND believes it can experience significant growth potential over the coming months

With nearly 16% of adults in the US reporting hearing trouble, the total addressable market of InnerScope Hearing Technologies (OTC: INND), a leading manufacturer, distributor, and retailer of FDA-Registered hearing aids, appears to be vast (https://ibn.fm/qD3tv). And as the population continues to age, the number of people that can benefit from hearing help is only expected to grow. To reach this large and ever-growing market, INND leverages a robust omnichannel market strategy to help an estimated 70 million people in North America that have some hearing impairment. This well-rounded and carefully executed strategy utilizes wholesale and retail distribution networks and DTC (direct-to-consumer) channel that involves InnerScope’s MyHearIQ.com eCommerce site and partner sites such as FSAstore.com, HSAstore.com, and WellDeservedHealth.com. In February, INND launched a new eCommerce website for HearingAssist, its wholly-owned subsidiary, located at https://hearingassist.com/. HearingAssist has been an established leader in the DTC hearing aid market since 2008. It is known as Walmart’s largest hearing aid supplier, with products available in 757 of its stores nationwide and over 500,000 hearing aids sold to date. INND also offers free self-check hearing screening in its kiosks installed in national pharmacy chains, big-box retailers, and national and local groceries chains. In December 2021, INND announced a deal with Giant Eagle, one of the country’s largest grocery and pharmacy chains with more than 470 locations in Pennsylvania, Ohio, West Virginia, Maryland, and Indiana. The agreement allows INND to initially deploy its proprietary hearing kiosks in six locations, with more to come (https://ibn.fm/hnzhn). INND continues to add new in-store hearing kiosks as part of its strategic rollout with multi-billion-dollar grocery and pharmacy retailers. As a veteran in the retail hearing aid space, with its founders who have over 70 years in the business, INND offers hearing aids that are FDA-registered, medical-grade devices. They come with professional remote programming and support from licensed hearing professionals through INND’s proprietary HearIQ App (available to download Free on Apple App Store and Google Play). INND also launched a new call center designed to deliver a superior personalized customer experience and elevate the support it provides to customers as it continues to accelerate nationwide growth. INND remains committed to empowering consumers to take control of their hearing care from the comfort of their homes by delivering the same quality of hearing technology and expert support as traditional providers but at a fraction of the cost. INND also offers a monthly subscription payment option that allows users to purchase hearing aids and get bi-annual free upgrades, making hearing care even more affordable. With its portfolio of innovative yet affordable hearing solutions targeted at the market that is expected to expand, INND is confident that there is a significant market opportunity for the company to experience explosive growth potential over the next 6 to 12 months (https://ibn.fm/xjThr). For more information, visit the company’s website at www.INND.com. NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

• Global diabetes-related healthcare expenses are estimated at $966 billion in 2021
• A recent report reveals 537 million adults currently live with diabetes, projected to rise to 643 million by 2030 and 783 million by 2045
• Glucose intake is an important factor in diabetes management, prevention and reversal
• NMRD’s sugarBEAT(R) wearable is a non-invasive, flexible CGM device helping diabetes and prediabetes patients monitor glucose levels
• NMRD’s MiBoKo metabolic health program recently launched, provides AI-powered insights based on glucose readings

Diabetes is a primary driver of chronic disease costing the healthcare services sector more than $966 billion in 2021. Nemaura Medical (NASDAQ: NMRD), a medical technology company that develops affordable diagnostic and digital tools for chronic disease management, is positioned to address the problem with sugarBEAT(R), a wearable, non-invasive and flexible Continuous Glucose Monitor (“CGM”) that can help diabetes and prediabetes patients monitor glucose levels to manage, prevent, and possibly reverse the disease. According to the International Diabetes Federation (“IDF”), diabetes is, “spiraling out of control.” The organization recently released a report detailing the disease’s progress, revealing that 537 million adults live with diabetes, a number projected to rise to 643 million by 2030 and 783 million by 2045. Besides affecting the health and wellbeing of patients, employers and insurers are burdened with diabetes-related expenses, currently estimated at over $966 billion – a 316% increase over the last 15 years. Nemaura addresses this through its flagship sugarBEAT(R) wearable CGM device and companion mobile app that provides helpful disease management insights. Unlike other CGM devices, sugarBEAT(R) is non-invasive and doesn’t require insertion of the sensor inside the skin: Users can now choose the days they wear the patch instead of a prolonged continuous-wear period lasting up to 14 days. Combined with MiBoKo, the company’s recently launched metabolic health program, both products provide valuable AI-powered insights that NMRD management believes will benefit one-third to half of the diabetes market. “A person’s response to sugar intake can influence many factors, from appetite and body weight, to sleep patterns, energy levels and even mood, not to mention also being a considerable factor in chronic diseases like diabetes, heart disease and dementia,” said NMRD CEO Dr. Faz Chowdhury. “With MiBoKo, we can extend our proprietary non-invasive device and sensor technology and interactive lifestyle and AI coaching programs beyond the traditional diabetes market and into an adjacent, yet separate, market application of metabolic health. At Nemaura, we continue to look for the intersection of patient comfort and convenience through an advanced and unique technology that addresses significant healthcare needs for large patient populations. We believe that MiBoKo offers insights into metabolic health in a user-friendly way unlike any other program on the market.” Founded in 2011, NMRD initially developed a single platform technology to measure blood markers at the skin’s surface. Since then, the company evolved its technology to address the global need for wearable glucose-monitoring devices, intersecting the diabetes, pre-diabetes, and weight loss markets. With several filed and pending patents, and significant trade secrets covering its technology platform, Nemaura is favorably positioned to lead the market with cost-effective, wearable, and non-invasive diabetes management devices. For more information, visit the company’s website at www.NemauraMedical.com. For more information on Miboko, visit www.Miboko.com. NOTE TO INVESTORS: The latest news and updates relating to NMRD are available in the company’s newsroom at https://ibn.fm/NMRD

• Cepton makes public debut after completing business combination with GCAC; appears on track to deliver on its vision to expand leading market position and drive value for stakeholders
• With initial market capitalization of around $1.4 billion, Cepton more than doubled its last private valuation of $615 million
• Company has grand plans for future; aims to be the one to extend LiDAR technology adoption from the luxury sector to mainstream

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) LiDAR solutions, made its Wall Street debut on February 11, 2022, following the successful completion of its previously announced business combination with Growth Capital Acquisition Corp. (“GCAC”), a Delaware special purpose acquisition company (or SPAC). The combined company has been renamed Cepton, Inc. with common stocks and warrants trading on the Nasdaq Capital Market under the ticker symbols “CPTN” and “CPTNW”, respectively. It will continue to be led by the current Cepton management team, including Dr. Jun Pei, Cepton’s Co-Founder and CEO, bolstered by George Syllantavos, co-CEO of GCAC, who will serve as a director of Cepton (https://ibn.fm/bAZnC). “Today is a special milestone for Cepton,” stated Dr. Jun Pei, Cepton’s Co-Founder and CEO. “We founded Cepton with the goal of enabling safe and autonomous transportation for everyone, and today’s announcement is another step in making that vision a reality. As a public company, we remain focused on the goals of mass-market LiDAR adoption in consumer vehicles and expanding our market leadership position while driving value for all of Cepton’s stakeholders.” George Syllantavos, co-CEO of GCAC, stated, “We are thrilled with the successful completion of this business combination. Cepton is a company at the forefront of technological advancements with the largest known ADAS LiDAR series production award in the industry and ongoing engagements with all of the Top 10 global OEMs. We are excited about the future and continuing to support the company in its public phase.” “I am impressed by the elegant technical solutions that Cepton is bringing to the lidar industry in addressing automotive ADAS needs. I’m certain that Cepton’s solutions will gain further commercial success in automotive and other markets. Time works in Cepton’s favor now that its public life has begun, and its vision is on track to materialize,” concluded Akis Tsirigakis, co-CEO of GCAC. As a Silicon Valley innovator of LiDAR-based solutions for automotive (ADAS/AV), smart cities, smart spaces, and smart industrial applications, Cepton is known for its patented Micro Motion Technology (MMT(R)), which allows for a balanced approach to performance, cost, and reliability. This innovative rotation-free, mirrorless, and frictionless technology enables Cepton to tackle challenges that currently restrict the applicability of LiDAR solutions to ultra-high-end vehicles only. Here, Cepton seems poised to deliver where others appear to have failed. Led by industry experts with decades of combined experience across advanced LiDAR and imaging technologies, Cepton set its eyes on taking LiDAR mainstream, focusing on the mass market commercialization of high performance, high-quality LiDAR solutions. Cepton and its tier-1 manufacturing partner, Koito manufacturing of Japan, was awarded the largest known series production award in the lidar industry by General Motors in support of its Ultra Cruise program. GM’s Ultra Cruise program will enable true hands-free driving across 95 percent of driving scenarios, covering more than 2 million miles of roads at launch in the United States and Canada, with the capacity to grow up to more than 3.4 million miles. Customers will be able to travel truly hands free with Ultra Cruise across nearly every road including city streets, subdivision streets and paved rural roads, in addition to highways. For more information, visit the company’s website at www.Cepton.com. NOTE TO INVESTORS: The latest news and updates relating to CPTN are available in the company’s newsroom at https://ibn.fm/CPTN

July 29th-31st, 2022 Venue: LOS ANGELES, CALIFORNIA To be held from July 29th to the 31st, NFT Expoverse is set to become the largest event focused on the mass adoption of blockchain technologies, aiming to attract a large number of renowned companies and personalities from the industry. Tickets, booth space, and sponsorship are all available. The event will showcase a broad spectrum of blockchain-related technologies such as Defi, dApps, P2E gaming, AR, VR, and the metaverse and welcome companies from any industries, including sports, gaming, retail, and entertainment, aiming to employ such technologies. From superior-technology brand stands to mammoth video walls to live-streaming speaker sessions, NFT Expoverse will have it all, defining itself as an interactive user-focused event showcasing some of the best and current blockchain-related projects. Recently joined exhibitors and sponsors include Tokenframe, Lunar, Charli3, Niftify, and the Cardano Defi Alliance. Blockchain technologies open up a world of possibilities, among them the ability to mint what is known as NFTs (Non-fungible tokens). These are blockchain-based tokens that represent unique digital assets like art, music, videos, and gaming items. NFTs are encrypted with the creator’s signature and use blockchain software to verify the ownership and originality of the assets. Several creators from around the globe are preparing for an exciting opportunity to elevate their profession at NFT Expoverse, where users will witness the metaverses, experience digital wonders, and try new special blockchain-based innovations. NFT Expoverse is organized by a devoted team of experts who are putting together a dynamic event featuring global influencers in a fun and exciting way. The speakers at the event will be prominent figures, considered authorities in the field of blockchain, from NFT artists to blockchain software developers and industry entrepreneurs. These individuals will share in-depth knowledge through engaging and motivational blockchain-related speeches. With a robust networking platform, entrepreneurs and enthusiasts from different niches will come together and interact on a common floor at NFT Expoverse. Startups and new businesses will leverage the networking sessions to connect with leading stalwarts and develop business ties. Eminent personas will take the speaker stage to share insights and discuss important issues in their respective fields. Some of the featured speakers include John Kraski of NFT Genius, Ian Scarffe of Blockchain Founders Fund, Tejas Chopra of Netflix, Monica Long of Ripple, and many others will be joining. This engaging exposition is open to attendees with interviews, webinars, specials, and news from insights experienced uniquely. The show will be held in Los Angeles, a perfect venue for heads, enthusiasts, entrepreneurs, creators, and companies to network and learn from each other. At the event, attendees will have access to the refreshments and networking breaks, in addition to the sessions at the NFT event. Furthermore, the venue is located near hotels where attendees can book a comfortable stay. Finally, attendees will be able to participate in the immersive aspiring sessions and VIP participants will enjoy the exclusive after-party. For more information, please visit https://nftexpo.com/

Small-cap companies, traders, investors, and businesses are invited to attend the 34th Annual ROTH Conference scheduled for March 13-15, 2022 be held at The Ritz Carlton, Laguna Niguel located in Dana Point, California. The conference will witness companies from a spectrum of diverse sectors, including consumer, energy, healthcare, industrial growth, metals & mining, sustainability, services, technology and more. Roth Conferences are one of the leading organizers of conferences for small-cap companies. Roth is a privately-owned investment banking firm dedicated to offering growth and networking opportunities to the small-cap public market. The previous years have shown some phenomenal responses from participants, sponsors and presenting companies. The event will feature approximately 450 participating companies and over 2,500 attendees will feature presentations from public and private companies in a variety of sectors. The event will showcase discussions, presentations, and keynotes by industry leaders and management teams on the latest trends, opportunities and prospects in the small-cap segment. The conference will begin at 7 am with Roth/CAF athletic activities, followed by conference registration, various activities that include meetings, chat presentations, and exhibits. Reputed leaders and thinkers of varied fields will put forth their valuable expertise and insights about the current and future trends of their respective fields. New businesses and startups can seek guidance and learn important industry strategies by attending these discussions and chats. After being organized as virtual events in 2020 and 2021, the 34th Annual Roth conference is being organized as an in-person event again this year. All safety and health protocols will be followed as per the federal, state, and local guidelines. The event will be held in a safe and secure environment. The agenda of the Roth Conference includes 1-on-1/small group meetings, analyst-selected fireside chats, thematic industry panels, and on-demand presentations. The event encourages networking opportunities for industries looking to establish long-term business connections and gain potential clients.  The Roth Conference experience promises to deliver entertainment and athletic charity events, along with business networking opportunities. An important addition to the conference is the New Issue Track, which will bring together newly-public companies, relatively unknown to investors. Many of these companies will be meeting with investors at the Roth Conference for the first time in a live format, offering:

• Company Presentations
• Analyst-Selected Fireside Chats
• Q&A Sessions
• 1-on-1 / Small Group Meetings
• Two Industry Panels

The Roth Cannabis Day & Reception will mark the closing event of the 34th Annual Roth Conference. At this event, shareholders and investors can gather pivotal information and guidance on how to make long-term profits from small-cap investments. They will also learn about future trends and the scope of expansion in their respective niches from experts, analysts, and influential personas. To learn more, please visit https://ibn.fm/GpjoC.

• Canadian-based clean energy solutions innovator FuelPositive Corp. is developing a means of producing and using ammonia for non-carbon polluting fuel
• Hydrogen has been touted as the ‘fuel of the future’, with the IEA predicting that hydrogen-based fuels will have to account for 30% of transportation fuels by 2050 to help the world achieve its zero emissions goals
• However, hydrogen has proven to be notoriously difficult to transport, given its highly volatile nature as well as its extremely low liquefying point (-253 degrees Celsius)
• Green Ammonia has emerged as both the best solution to transport and store hydrogen, as well as a renewable fuel source in its own right

Historically, passengers looking to take the 80-minute train journey linking the coastal town of Cuxhaven, Germany and Buxtehude, a commuter hub located just outside the city limits of Hamburg, would board the diesel train service run by German train operator, EVB. However, that all changed one Sunday morning in September 2018; on that day, the Coradia iLint, the world’s first hydrogen-powered passenger train, came into service on the nearly 100 kilometers of line running between the two destinations (https://ibn.fm/qXU3f). In addition to its efficient service – the train could achieve speeds of up to 140 kilometers per hour (86 miles per hour), the Coradia iLint marked a dramatic departure from the polluting trains of the past. The average diesel-powered train generates carbon emissions of as much as 27.5g CO2e per tonne kilometer (https://ibn.fm/8TLRl); the Coradia iLint, in turn, emits only steam and condensed water, with the latter element so pure, it can be used as drinking water. Although the environmental bona fides of hydrogen fuel cells and other pure hydrogen applications are undeniable – a 2021 International Energy Agency report forecast that to hit zero emissions by 2050, hydrogen-based fuels should account for nearly 30 percent of transport fuels by 2050 (https://ibn.fm/cuqld), the difficulty in effectively transporting and storing the fuel has hampered its mass adoption to date. Canadian-based clean energy solutions innovator, FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) has sought to resolve this conundrum through the development of its proprietary carbon-free green ammonia technology. Green ammonia, so called for its production process using renewable energy sources, has been shown to be one of the most effective mediums for the proper storage and transportation of energy from renewable power sources. Historically utilized to manufacture agricultural fertilizers, green ammonia has also been found to be one of the most efficient and low-cost means of transporting hydrogen. FuelPositive’s hydrogen-ammonia synthesizer technology provides the means of storing hydrogen as green ammonia for effective transportation and storage, with the option of easy conversion back to hydrogen for use in hydrogen fuel cells and other functions. Although pure hydrogen has often been touted as the ‘fuel of the future’, green ammonia has also been shown to be effective as an energy source in its own right; in fact, the gas has been found to boast a higher energy density, at 12.7 megajoules per liter than liquid hydrogen, at 8.5 MJ/L (https://ibn.fm/RFfT6). In other words, green ammonia can store and generate nearly 50 percent more energy per liter than the equivalent volume of liquid hydrogen. Moreover, liquid hydrogen must be cooled to minus 253 degrees Celsius to remain in liquid form, whereas green ammonia can become liquid at a mere minus 33 degrees Celsius, significantly decreasing the logistical challenges in transporting the fuel. As a result, green ammonia has already been touted as a vital potential fuel for the global shipping industry, with the latter accounting for approximately two to three percent of the world’s annual greenhouse gas emissions (https://ibn.fm/OaUAV). The IEA has revealed that green ammonia has an essential role to play in bringing global emissions to net zero, alongside biofuels and hydrogen. Jimmy Faria, a chemical engineer at the University of Twente in the Netherlands who has delved into the use of ammonia, forecast that green ammonia will continue to gain prevalence as carbon prices rise further: “I think ammonia is probably the future for liquid fuels” (https://ibn.fm/yz1Ks). With its technology well suited towards the production and transportation of green ammonia, FuelPositive Corp looks well positioned to capitalize on the ongoing global shift towards renewable energy sources and hydrogen-based fuels in particular. For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• RWB has received all regulatory approvals and closed its acquisition of PharmaCo, a Michigan-based marijuana company
• This acquisition opens RWB to over 22 properties, including dispensaries and cultivation sites, giving it complete control of all its operations, from cultivating the product to selling it
• It marks a key milestone for the company and its shareholders as it continues to execute key components of its growth strategy
• For the 2022 calendar year, the company looks to extend its branded product lines, update its dispensaries, create supply chain efficiencies, and grow revenue and profitability

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) is slowly positioning itself to be one of the most prolific multi-state operators in cannabis and hemp-derived product lines in the United States. Its strategy has mainly consisted of acquisitions across states like Illinois and Massachusetts, with plans to expand to California and Florida. In what marks a significant milestone for RWB, it has announced having received all regulatory approvals and closing its acquisition of PharmaCo, a Michigan-based marijuana company. This acquisition expands RWB’s footprint within the state, having initially only had a single product line in this market- the Platinum Vape(R) brand (https://ibn.fm/fpiFt). “I am pleased to announce that we have closed on the PharmaCo acquisition and now control all aspects of our Michigan Operations,” noted Brad Rogers, the Chairman and Chief Executive Officer (“CEO”) of RWB. “This is a major milestone for RWB and its shareholders as we continue to execute key components of our growth strategy and build our house of brands across our core markets, as promised,” he added. The acquisition was made via RWB Michigan, LLC, a wholly-owned RWB subsidiary, at a consideration of 37 million RWB units. Each unit consisted of one common share and one series 2 convertible preferred share in the capital of RWB. The transaction also involved converting $30 million in previous advanced loans to PharmaCo into preferred shares in the company issued by RWB Michigan immediately before closing, giving the company 100% ownership of PharmaCo. This successful acquisition gives RWB access to 22 owned properties, including nine dispensaries and three cultivation sites in Glendale, Marquette, and Au Gres. RWB has also expanded its human resources within the State of Michigan by 180 employees and seeks to offer them competitive wages and incentives to share in the rewards of helping the company achieve its goals. “We welcome the many talented PharmaCo employees to the RWB team to continue their good work,” noted Mr. Rogers. “We value their contributions and feel it is important to pay competitive wages and provide key leaders and employees with a stake in the company so they can share in the rewards of helping RWB achieve its goals,” he added. Going forward, RWB looks to execute its initiatives that include extending its branded product lines, updating its dispensaries to heighten the customer experience, creating supply chain efficiencies, and growing revenue and profitability. This is possible given that the company now controls all Michigan operations, from growing the product to selling it. Michigan is one of the top cannabis markets in the United States, accounting for over $1.79 billion in sales in 2021 alone. “We are now in the driver’s seat on over 20 assets across Michigan- one of the largest and fastest-growing cannabis markets in the country,” reckoned Mr. Rogers. For more information, visit the company’s website at www.RedWhiteBloom.com. NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF